The DOI matches its Crossref record.
Breast Cancer in Iranian Woman: Incidence by Age Group, Morphology and Trends
Open accessAbstract
BACKGROUND: Breast cancer is the most common cancer and the first cause of cancer death in women worldwide, with infiltrating duct carcinoma as the most common morphology. This study aimed to investigate trend of breast cancer incidence by age groups and histological changes in Iranian women between 2003 and 2008. MATERIALS AND METHODS: This is analytic study, carried out based on re-analysis of the Cancer Registry Center report of health deputy for women's breast cancer in Iran during a 6-year period (2003-2008). Statistical analysis for incidence time trends and morphology change percentage carried out joinpoint regression analysis using the software Joinpoint Regression Program. RESULTS: A total of 36,340 cases were reported for Iranian women in the six years. Analytical trend showed an increasing incidence trend with significant annual percentage change (APC) of 15.2 (CI: 11.6 to 18.8). The lowest and highest significant increased trend were related to age groups of 40 to 44 years and above 85 years, respectively; with APCs of 13.0 and 25.1, respectively. Of total cases, 78.7% of cases were infiltrating duct carcinoma, decreasing from 82.0% in 2003 to 76.6% in 2008, which was significant with an APC equal to -1.76 (CI:-2.7 to -0.8). CONCLUSIONS: The incidence trend of breast cancer is rising in Iranian women. The highest incidence was observed in the age groups 45-65 and 80-85. In conclusion, to reduce breast cancer incidence and its burden, preventive and screening programs for breast cancer, especially in young women, are recommended in Iran.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
About 33% of breast cancer survivors feel worried about their health even after treatment.
“About 33% of breast cancer survivors feel worried about their health, even after treatment (1,2).”
From Predicting Health Anxiety Based on Intolerance of Uncertainty: Investigating the Mediating Role of Cognitive Flexibility and Cyberchondria in Breast Cancer Survivors (2023) · cites this paper as [2]
The Introduction and Discussion address breast cancer incidence, age groups, morphology, and risk factors, not survivors’ worries after treatment. Searches for the 33% figure and for post-treatment health concerns found no passage addressing the claim; the Discussion’s 33.21 figure is an incidence rate per 100,000, not a percentage of survivors. (LLM, conf=0.75)
Experimental — accuracy not yet measuredPrevious studies demonstrated that mindfulness-based therapy improves pain anxiety and cognitive regulation of negative and positive emotions in breast cancer patients.
“Previous studies also demonstrated that mindfulness-based therapy improves pain anxiety and cognitive regulation of negative and positive emotions in breast cancer patients. (4, 5)”
From Effectiveness of Mindfulness Training in Emotion Regulation and Distress Tolerance among Breast Cancer Patients (2024) · cites this paper as [5]
The Introduction describes a study of breast cancer incidence, age groups, and histology in Iranian women; the Discussion addresses screening and diagnosis. Searches for mindfulness-based therapy, pain anxiety, and emotion regulation found no passage addressing the claimed treatment effects in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 26
- 2015, Asian Pac J Cancer Prev, 16, 2757, 10.7314/APJCP.2015.16.7.2757 · DOI
- 2008, Pharm Res, 25, 2097, 10.1007/s11095-008-9661-9 · DOI · Paper page
- 2004, Radiol, 233, 830, 10.1148/radiol.2333031484 · DOI
- 2005, Cancer Detect Prev, 29, 412, 10.1016/j.cdp.2005.06.009 · DOI
- 2011, Ann Oncol, 22, 329, 10.1093/annonc/mdq396 · DOI
- 2011, J Physical Activity Health, 8, 27, 10.1123/jpah.8.1.27 · DOI
- 2010, International J Cancer, 127, 2893, 10.1002/ijc.25516 · DOI
- 2009, Ann Int Med, 151, 716, 10.7326/0003-4819-151-10-200911170-00008 · DOI
- 2011, CA Cancer J Clin, 61, 69, 10.3322/caac.20107 · DOI
- 2010, Cancer Epidemiology Biomarkers Prev, 19, 1893, 10.1158/1055-9965.EPI-10-0437 · DOI · Paper page
- 2007, Breast Cancer Res, 9, R28, 10.1186/bcr1672 · DOI
- 2015, Asian Pac J Cancer Prev, 16, 1409, 10.7314/APJCP.2015.16.4.1409 · DOI
- 2002, Radiol, 225, 165, 10.1148/radiol.2251011667 · DOI
- 2003, JAMA, 289, 1421, 10.1001/jama.289.11.1421 · DOI
- 2014, South Asian J Cancer, 3, 101, 10.4103/2278-330X.130442 · DOI
- 2009, Ann Oncol, 20, 556, 10.1093/annonc/mdn642 · DOI
- 2007, Breast J, 13, 383, 10.1111/j.1524-4741.2007.00446.x · DOI
- 2013, J Mazandaran Univ Med Sci, 23, 113
- 2015, Med J Islamic Republic Iran, 29, 752
- 2015, Global J Health Sci, 8, 146
- 2015, Asian Pacific J Cancer Prev, 16, 4955, 10.7314/APJCP.2015.16.12.4955 · DOI
- 2001, APMIS, 109, 321, 10.1034/j.1600-0463.2001.090501.x · DOI
- 2005, World J Surg Oncol, 3, 67, 10.1186/1477-7819-3-67 · DOI
- 2014, J Res Med Sci, 19, 319
- 2014, J Res Health Sci, 14, 210
- 2015, Chin J Cancer Res, 27, 13
Cited by
Sorted by citations
Mohammadinia, N., Department of psychology, I. A. U. O. S., Nasehi, A., Department of Medicine Educational and Rehabilitation, I.-H. I. O. A. S. A. T., Niusha, B., & Department of psychology, I. A. U. O. S. (2023) · Iranian Journal of Breast Diseases · doi:10.30699/ijbd.16.3.65 · Cited by 4
Parsaee, S., Jahani, N., Salehiniya, H., & Raeison, M. (2024) · Journal of Breast Diseases · doi:10.61186/ijbd.17.1.84
Self-citation
Metadata
- Authors
- Rafiemanesh, H., Salehiniya, H., & Lotfi, Z.
- Affiliations
- Shahid Beheshti University (IR)
- Venue
- Asian Pacific Journal of Cancer Prevention
- Published
- 2016-04-11
- Volume
- 17
- Issue
- 3
- Pages
- 1393-1397
- ISSN
- 1513-7368 (ISSN-L)
- OpenAlex
- W2407179169
- Cited by
- 64
- References
- 0
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 9 · 2023: 13 · 2022: 5 · 2021: 8 · 2020: 8 · 2019: 6 · 2018: 9 · 2017: 1
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Asian Pacific Journal of Cancer Prevention (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- breast cancer incidence, Iranian women, age-specific incidence, histomorphology, infiltrating duct carcinoma, incidence trends, young women, breast cancer screening, cancer registry data
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Breast Neoplasms, Female, Follow-Up Studies, Humans, Iran, Mammography, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Prognosis, Registries, Retrospective Studies, Incidence, Carcinoma, Ductal, Breast, Carcinoma, Lobular, Carcinoma, Medullary, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
